Performance Evaluation and Cross-Reactivity from Insulin Analogs with the ARCHITECT Insulin Assay,
Authors:
- 1 July 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (7) , 1423-1426
Abstract
Background: Insulin measurement is used for the diagnosis of hypoglycemia and for insulin pharmacokinetic evaluations. We assessed the analytical and clinical performance of the ARCHITECT® insulin assay, a chemiluminescent immunoassay recently introduced for the ARCHITECT i2000 fully automated immunoassay analyzer (Abbott Laboratories). We also tested whether major insulin analogs cross-reacted with the immunoassay reagents. Methods: We used Clinical and Laboratory Standards Institute protocols to assess the analytical performance of the ARCHITECT insulin assay and compared its accuracy with that of the E-test TOSOH II (IRI) from TOSOH Corporation. We used 3 recombinant insulin analogs (lispro, aspart, and glargine) to evaluate the cross-reactivity of insulin analogs with the ARCHITECT immunoassay reagent. Results: The total CV for the ARCHITECT assay was Conclusions: The ARCHITECT insulin assay showed favorable basic performance, including reproducibility, dilution linearity, detection limit, and effects of interfering substances. When interpreting results, clinicians and laboratory pathologists should be aware of the cross-reactivity of the ARCHITECT and other immunoassays to specific insulin analogs prescribed to diabetes patients.Keywords
This publication has 13 references indexed in Scilit:
- Cross-Reactivity of Three Recombinant Insulin Analogs with Five Commercial Insulin ImmunoassaysClinical Chemistry, 2004
- Follow-up Report on the Diagnosis of Diabetes MellitusDiabetes Care, 2003
- Report of the American Diabetes Association's Task Force on Standardization of the Insulin AssayDiabetes, 1996
- Report of the American Diabetes Association's Task Force on standardization of the insulin assayDiabetes, 1996
- Immunoanalysis of human insulin using monoclonal antibodies reveals antigenicity of evolutionarily conserved residuesMolecular Immunology, 1995
- The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse modelDiabetologia, 1994
- Characterization of two epitopes on insulin using monoclonal antibodiesMolecular Immunology, 1985
- Immunological properties and biological effectiveness of insulin analogues substituted at position B30Diabetologia, 1984
- Mapping epitopes on the insulin molecule using monoclonal antibodiesEuropean Journal of Immunology, 1983
- Ir-gene control of immunogenicity of insulin and A-chain loop as a carrier determinantNature, 1975